Mkts

Axsome Therapeutics, Inc.

NASDAQ: AXSM
$129.36-6.32 (-4.66%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
128.23135.09
52-week range
123.00260.19
Today
Open133.92
Previous close129.36
Volume653.3K
Valuation
Market cap6.90B
P/E ratio—
EPS (TTM)-3.06
Income & risk
Dividend / yield—
Beta0.87
Avg volume822.2K
Discussion

AXSM News

Stories mentioning AXSM from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue191,203195,999170,992150,042121,463118,766104,76287,166
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development52,67748,79140,16249,54144,78555,00645,38849,853
Sales General & Admin184,996169,297150,235130,280120,787113,27195,564103,554
Total Operating Expenses
Operating Income (Loss)(63,357)(26,957)(46,109)(36,714)(56,982)(72,617)(62,624)(78,046)
Interest Income
Interest Expense3,092(13,725)(3,375)(4,086)5,258(5,430)(5,666)(5,079)
Other Expense
Pretax Income(64,542)(28,129)(47,229)(48,933)(59,413)(74,827)(64,602)(79,345)
Tax Provision0.00430.000.00(960.00)0.0085.000.000.00
Net Income (Loss)(64,542)(28,559)(47,229)(47,973)(59,413)(74,912)(64,602)(79,345)
Earnings Per Share (Basic)(1.26)(0.57)(0.94)(0.97)(1.22)(1.56)(1.34)(1.67)
Earnings Per Share (Diluted)(1.26)(0.57)(0.94)(0.97)(1.22)(1.56)(1.34)(1.67)
Weighted Average Shares Outstanding (Basic)51,19849,74750,02249,44248,87147,91448,14147,573
Weighted Average Shares Outstanding (Diluted)51,19849,74750,02249,44248,87147,91448,14147,573

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AXSM

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a stock listed on the Nasdaq Stock Market under the ticker symbol AXSM. It last traded at $129.36 (Nov 20, 2026, 4:00 PM ET), down 4.7% on the day. That gives Axsome Therapeutics a market capitalisation of $6.9B.

Over the past 52 weeks AXSM has traded between $123.00 and $260.19.

Revenue for the quarter ended Mar 31, 2026 was $191.2M; a net loss of $64.5M. Revenue was up 57.4% from $121.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$191.2M-$64.5M-33.8%
Dec 31, 2025$196.0M-$28.6M-14.6%
Sep 30, 2025$171.0M-$47.2M-27.6%
Jun 30, 2025$150.0M-$48.0M-32.0%

From Axsome Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…